Overall, the global ENT balloon dilation device market was valued at $933 million in 2022. This is expected to increase over the forecast period at a CAGR of 3.9% to reach $1.2 billion.

The full report suite on the global market for balloon dilation devices focuses on the balloon sets, and it does not include the market’s extended set.

MARKET DATA INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2029, and Historical Data to 2019
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

GLOBAL ENT BALLOON DILATION DEVICE MARKET INSIGHTS

One major market driver for this market is the one-sitting, minimally invasive nature of the procedure. Oftentimes, patients experience minimal bleeding, and they can return to their normal routine within hours. Because of the above-mentioned reasons, these devices have started to become popular around the world.

GLOBAL ENT BALLOON DILATION DEVICE MARKET SHARE INSIGHTS

The Global ENT balloon dilation device market was controlled by Acclarent, Stryker, and Medtronic.Acclarent was the first competitor in the balloon sinus dilation (BSD) device market when it first launched its Relieva® Balloon Sinuplasty system. Acclarent’s acquisition by Johnson & Johnson in 2010 provided the necessary sales and marketing resources needed to compete in this growing market. The company owes much of its current success to its early entry into this market and its affiliation with Johnson & Johnson.

MARKET SEGMENTATION SUMMARY 

• ENT Balloon Dilation Device Market – MedCore – Includes:
  • Balloon Sets

Research Scope Summary

WHY CHOOSE IDATA?

• Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
• Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
• Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
• Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

FREE Sample Report